NCOA3 and prostate carcinoma: Targeting NCOA3 via genistein reduces cell proliferation and suppresses the development of prostate cancer in transgenic rat models (Harper et al. 2009), although knockout of NCOA1 does not significantly alter prostate cancer initiation and progression (Xu & Li 2003).